Helen of Troy (HELE)
(Delayed Data from NSDQ)
$59.73 USD
+0.56 (0.95%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $59.73 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$59.73 USD
+0.56 (0.95%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $59.73 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth F Momentum B VGM
Zacks News
Estee Lauder (EL) Looks Solid on Online Business & Savings
by Zacks Equity Research
Estee Lauder (EL) is implementing new technology and digital experiences to boost online sales. Also, strength in the Skin Care category is driving growth.
Helen of Troy's (HELE) Q3 Earnings Beat Estimates, Sales Up Y/Y
by Zacks Equity Research
Helen of Troy's (HELE) third-quarter fiscal 2021 results reflect strength across the Beauty and the Health & Home segments along with gains in online business.
Helen of Troy (HELE) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Helen of Troy (HELE) delivered earnings and revenue surprises of 20.90% and 13.43%, respectively, for the quarter ended November 2020. Do the numbers hold clues to what lies ahead for the stock?
Will High Demand & Online Strength Continue to Aid Colgate (CL)?
by Zacks Equity Research
Despite cost and currency-related headwinds, strong product demand and sturdy online show are likely to help Colgate (CL) stay put amid this COVID-19 crisis.
Here's Why You Should Add Procter & Gamble (PG) to Your Portfolio
by Zacks Equity Research
Procter & Gamble (PG) has been gaining from strong demand for its products, underlying strength in brands and appropriate strategies. Also, cost-saving initiatives bode well.
Helen of Troy (HELE) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Helen of Troy's (HELE) third-quarter fiscal 2021 results are likely to reflect strength in Leadership brands and online sales. However, unfavorable currency rates are a concern.
Earnings Preview: Helen of Troy (HELE) Q3 Earnings Expected to Decline
by Zacks Equity Research
Helen of Troy (HELE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Factors That Make Helen of Troy (HELE) a Solid Pick for 2021
by Zacks Equity Research
Helen of Troy (HELE) is focused on making solid investments in Leadership Brands. Also, strength in the online business is yielding positive results.
Helen of Troy's (HELE) New Revlon License to Boost Beauty Business
by Zacks Equity Research
Helen of Troy Limited (HELE), via its subsidiaries, enters into a 100-year exclusive Trademark License Agreement with Revlon to license the trademark for hair care appliances and tools of the latter.
Helen of Troy (HELE) Up 6.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Helen of Troy (HELE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Helen of Troy (HELE) Earnings & Sales Beat Estimates in Q2
by Zacks Equity Research
Helen of Troy's (HELE) second-quarter fiscal 2021 results reflect better-than-expected sales and earnings on strength across all segments, along with gains in online business.
Coty to Gain From Kylie Skin International DTC Website Launch
by Zacks Equity Research
Coty (COTY) unveils the launch of Kylie Skin's direct-to-consumer flagship website in global markets, including France, Germany, the United Kingdom and Australia.
Helen of Troy (HELE) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Helen of Troy (HELE) delivered earnings and revenue surprises of 57.74% and 18.70%, respectively, for the quarter ended August 2020. Do the numbers hold clues to what lies ahead for the stock?
All You Should Know Before Helen of Troy's (HELE) Q2 Earnings
by Zacks Equity Research
Helen of Troy's (HELE) second-quarter fiscal 2021 results are likely to reflect strength in Leadership brands and online sales.
Nu Skin (NUS) Rallies on Impressive Sales Projection for Q3
by Zacks Equity Research
Nu Skin (NUS) anticipates third-quarter 2020 revenues in the range of $700-$703 million ahead of its previously provided guidance.
Strength Seen in Nu Skin (NUS): Stock Soars 9.6%
by Zacks Equity Research
Nu Skin (NUS) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
Helen of Troy (HELE) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Helen of Troy (HELE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Helen of Troy (HELE) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Helen of Troy (HELE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here is Why Growth Investors Should Buy Helen of Troy (HELE) Now
by Zacks Equity Research
Helen of Troy (HELE) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Sanderson Farms' (SAFM) Shareholder-Friendly Moves Look Solid
by Zacks Equity Research
Sanderson Farms (SAFM), which recently raised its quarterly dividend, is benefiting from its strategic growth efforts.
Colgate Up More Than 10% YTD on Demand: Will It Move Higher?
by Zacks Equity Research
Colgate (CL) remains well placed with strong product demand, robust pricing efforts and sturdy online show, which are boosting organic sales. However, costs and currency-related headwinds persist.
Nu Skin is Poised on Customer Base Growth & Product Pipeline
by Zacks Equity Research
Strength in Nu Skin's (NUS) customer base driven by its effective strategies is yielding. Also, it is focused on empowering sales leaders through engaging technology platforms.
Coronavirus-Led Woes Hurt Coty (COTY), E-commerce Looks Solid
by Zacks Equity Research
Weakness in the Consumer Beauty segment along with currency headwinds are a concern for Coty (COTY). Nevertheless, its strategic partnerships and online business bode well.
Zacks Industry Outlook Highlights: Helen of Troy, Nu Skin, Inter Parfums, e.l.f. Beauty and Estee Lauder
by Zacks Equity Research
Zacks Industry Outlook Highlights: Helen of Troy, Nu Skin, Inter Parfums, e.l.f. Beauty and Estee Lauder
NUS or HELE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
NUS vs. HELE: Which Stock Is the Better Value Option?